Selank Nasal Spray

What is Selank?

Selank is a synthetic heptapeptide developed by the Institute of Molecular Genetics of the Russian Academy of Sciences in the late 90s and early 2000s. It is a synthetic analogue of the human tetrapeptide tuftsin, which plays a crucial role in immune system regulation. Selank was designed to provide anxiolytic and nootropic effects while maintaining a favourable safety profile in preclinical research.

Selank was modified from its parent peptide, tuftsin, and enhanced with additional amino acids to improve its bioavailability and stability. It has been extensively studied on animal models, researching its effects on cognitive function, immune modulation and anxiety. Although it has not been as extensively studied in humans, it has undergone clinical human trials with promising data.

Selank is not FDA-approved, but it does have approval via prescription in some countries for anxiety disorders.

Why is Nasal Delivery Superior?

The nasal delivery of Selank is a key part of its effectiveness, giving it clear benefits over traditional methods:

1. Fast Absorption: Nasal sprays allow for faster absorption of Selank due to the blood vessels in the nasal lining being closer to the surface, which allows the spray to go straight into the bloodstream. Because of this, it skips the digestive process that can reduce the effectiveness of some peptides. 
2. Ease of Use: Nasal sprays are simple to use, allowing for easier control and dosing and eliminating the more complex injectable method.
3. Straightforward Delivery to Target Areas: Studies show that taking Selank through the nose might deliver it more to certain areas than other methods. The nasal cavity’s closeness to the blood-brain barrier makes it a useful way to deliver peptides for neurological research.

How Does Selank Work?

Selank operates through multiple mechanisms in the central nervous system and immune system:

• Monoamine neurotransmitter modulation: Selank influences serotonin, dopamine, and norepinephrine metabolism in the brain. Research demonstrated that it normalises neurotransmitter levels in stressed animal models, contributing to its anti-anxiety properties.
• GABA system effects: Research shows that Selank has an impact on GABA-related brain activity but doesn’t bind to GABA receptors. It plays a role in changing the activity of genes tied to GABA and affects how inhibitory signals are passed in the brain.
• BDNF production boost: Studies in animals revealed that giving Selank raised BDNF levels in the hippocampus. This protein is important for brain flexibility, learning, and creating memories.
• Blocking enkephalin breakdown: Selank stops certain enzymes from breaking down enkephalins, which are natural opioids the body uses to manage pain and emotions. This helps explain its effects on reducing stress.
• Immune system regulation: Selank, acting as a tuftsin analogue, has an influence on the activity of immune cells. Research indicated that it can adjust cytokine levels and boost the body’s immune response in test models.
• Gene expression modulation: Studies found that Selank changes how genes linked to neurotransmitter production, immune activity, and stress reactions work. This hints at its wide-ranging role in regulating processes at the molecular level.

What Are the Potential Benefits of Selank?

Selank has undergone multiple preclinical and clinical trials. These have shown the following potential benefits:

1. Cognitive enhancement: In animal models, Selank improved memory performance and learning. This was found after a series of cognitive tests demonstrated improved information-processing speed and enhanced attention span.
2. Anti-anxiety effects: Human clinical trials reported a significant improvement in anxiety symptoms when compared to placebo groups. In animal studies, Selank was able to reduce anxiety-like behaviours without the typical sedation often seen in most anxiety medications.
3. Immune modulation: Research suggested that when tested on immunocompromised animal subjects, Selank demonstrated enhanced immune function. It does this by normalising cytokine profiles and improving resistance to some viral infections.
4. Reduced stress: In animal-based clinical trials, Selank was able to normalise cortisol levels and prevent immune suppression caused by stress.
5. Sleep quality: While not explicitly tested for this benefit, some studies have indicated that Selank improved sleep quality and sleep cycles without daytime drowsiness.
6. Neuroprotective properties: Published research has shown that Selank protected neurons from excitotoxicity and oxidative stress. While animal studies demonstrated a reduction in neuronal damage following ischaemic events once Selank was administered.
7. Mood regulation: In human clinical trials, participants with anxiety disorders reported improvements in their emotional stability and mood.

Safety for the Use of Selank

Selank has been studied in numerous preclinical and clinical trials. However, comprehensive long-term safety data remains limited:

• Clinical trial data: Human trials have reported minimal adverse effects at therapeutic doses. The most commonly reported side effects were mild and transient, including occasional headaches or nasal irritation with intranasal administration.
• No dependency potential: Research indicated that Selank does not produce physical dependence or withdrawal symptoms, distinguishing it from traditional anxiolytic medications.
• Hormonal considerations: Due to its influence on neurotransmitter systems and stress hormones, researchers should monitor endocrine parameters in experimental protocols.
• Individual variability: As with any medication or peptide, results and effectiveness will depend and vary from person to person.
• Interaction potential: Selank’s effects on monoamine and GABAergic systems suggest potential interactions with compounds that also affect these pathways. Researchers should exercise caution when combining Selank with other neuroactive substances.
• Long-term use: There is no data on continued long-term effects yet.

Selank Data Sheet

• CAS Number: 129954-34-3
• Molecular Weight (g/mol): 751.9
• Chemical Formula: C₃₃H₅₇N₁₁O₉
• Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro
• PubChem CID: 11765600
• ChemSpider: 9940290
• ChEMBL: CHEMBL4297607

Conclusion

Selank is an important research peptide used to explore how anxiety, brain function, and the immune system work. Scientists use it to study these areas because it works in many ways. It helps regulate monoamines, boosts BDNF expression, and interacts with the immune system, which makes it a key tool to understand complex brain and immune system activities.

Studies have indicated that Selank helps to lower anxiety, improve thinking skills, and adjust how the immune system acts in lab research. Trials with humans have also shown it could help manage anxiety and support mental function, with fewer risks when compared to common anxiety medications.

Selank works in a unique way and has very few side effects, which makes it a useful tool to study how stress, anxiety, and the immune system are connected.

UK SARMs provides Selank nasal spray for research only.

References

Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats – PubMed

Selank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission – PubMed

Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats – PubMed

[Optimization of the treatment of anxiety disorders with selank] – PubMed

Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity – PubMed

[Experimental optimization of learning and memory processes by selank] – PubMed

[Immunomodulatory effects of selank in patients with anxiety-asthenic disorders] – PubMed

Antiviral properties of structural fragments of the peptide Selank – PubMed

[A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders] – PubMed

[Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia] – PubMed

GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells – PubMed

[Antiviral activity of immunomodulator Selank in experimental influenza infection] – PubMed